This is a long debate and I think there is no easy answer. There is an article about expensive drugs (targeting rare diseases): http://www.technologyreview.com/

This is a long debate and I think there is no easy answer. There is an article about expensive drugs (targeting rare diseases): http://www.technologyreview.com/featuredstory/520441/a-tale-of-two-drugs/ http://www.technologyreview.com/featuredstory/520441/a-tale-... Also recent bayer-india case makes things more complicated: http://www.reuters.com/article/2013/03/04/us-india-bayer-idUSBRE9230LC20130304 http://www.reuters.com/article/2013/03/04/us-india-bayer-idU...